Physician
Hammadeh, Rasheed
Hammadeh, Rasheed was paid $1.42M by Medicaid between Jan 2018 and Nov 2024, across 97 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 28% of everything it billed.
33Billing provider infoHAMMADEH, RASHEED
MAYWOOD, IL 60153
MAYWOOD, IL 60153
33aNPI1942270392assigned 01/26/2006
33bProvider typeAnatomic Pathology Physician
28Total paid$1.42M
24GClaims185,579
24DCodes billed97
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology Physician providers in Illinois
Rank by total paid#5 of 38
Median peer was paid$56K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96 | $3K | |
| 2019 | 207 | $5K | |
| 2020 | 302 | $6K | |
| 2021 | 823 | $23K | |
| 2022 | 24,867 | $271K | |
| 2023 | 85,169 | $645K | |
| 2024incomplete | 74,115 | $470K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 28% | 5,768 | 5,484 | $392K |
| 80053 | Comprehensive metabolic panel | 6.2% | 17,661 | 12,325 | $89K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.6% | 3,378 | 3,062 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.5% | 3,608 | 3,495 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.0% | 25,345 | 16,125 | $71K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.3% | 2,003 | 1,864 | $61K |
| 88307 | 3.5% | 750 | 614 | $50K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.3% | 12,309 | 6,647 | $48K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.8% | 1,855 | 1,791 | $40K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.8% | 1,842 | 1,778 | $40K |
| 83735 | 2.7% | 11,918 | 5,423 | $38K | |
| 84484 | 2.6% | 9,526 | 7,352 | $37K |
85 more codes
| 83880 | 2.4% | 2,901 | $34K | |
| 84145 | 1.7% | 1,439 | $24K | |
| 87040 | 1.5% | 2,540 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.4% | 3,989 | $20K |
| 83690 | 1.2% | 5,316 | $18K | |
| 85027 | 1.2% | 6,210 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,959 | $16K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 405 | $14K |
| 83605 | <1% | 2,898 | $14K | |
| 85730 | <1% | 3,676 | $11K | |
| 88342 | <1% | 606 | $11K | |
| 81001 | <1% | 6,118 | $8K | |
| 82077 | <1% | 806 | $8K | |
| 84702 | <1% | 1,751 | $8K | |
| 86850 | <1% | 2,638 | $8K | |
| 88141 | <1% | 573 | $8K | |
| 87641 | <1% | 361 | $8K | |
| 86901 | <1% | 3,433 | $7K | |
| 85610 | <1% | 3,710 | $7K | |
| 80074 | <1% | 357 | $7K | |
| 87806 | <1% | 627 | $6K | |
| 84100 | <1% | 3,277 | $6K | |
| 85379 | <1% | 1,586 | $6K | |
| 86900 | <1% | 3,433 | $6K | |
| 88341 | <1% | 109 | $5K | |
| 82803 | <1% | 509 | $5K | |
| 80061 | Lipid panel | <1% | 1,224 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,472 | $5K |
| 87340 | <1% | 728 | $4K | |
| 80076 | <1% | 1,038 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 59 | $3K |
| 82607 | <1% | 607 | $3K | |
| 82550 | <1% | 1,397 | $3K | |
| 82746 | <1% | 584 | $3K | |
| 88112 | <1% | 146 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 16 | $3K |
| 82728 | <1% | 717 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 17 | $3K |
| 83550 | <1% | 661 | $3K | |
| 80069 | <1% | 686 | $3K | |
| 87210 | <1% | 1,051 | $2K | |
| 81003 | <1% | 2,372 | $2K | |
| 86706 | <1% | 368 | $2K | |
| 86704 | <1% | 311 | $2K | |
| 82570 | <1% | 1,040 | $2K | |
| 80202 | <1% | 339 | $2K | |
| 88304 | <1% | 127 | $2K | |
| 84439 | <1% | 499 | $2K | |
| 82140 | <1% | 463 | $2K | |
| 88173 | <1% | 45 | $2K | |
| 87070 | <1% | 643 | $2K | |
| 86140 | <1% | 807 | $2K | |
| 84703 | <1% | 525 | $2K | |
| 87088 | <1% | 347 | $2K | |
| 86803 | <1% | 224 | $2K | |
| 86592 | <1% | 859 | $2K | |
| 83615 | <1% | 712 | $2K | |
| 81025 | <1% | 594 | $2K | |
| 82247 | <1% | 664 | $1K | |
| 87205 | <1% | 798 | $1K | |
| 87075 | <1% | 199 | $1K | |
| 84132 | <1% | 882 | $1K | |
| 84300 | <1% | 535 | $1K | |
| 82248 | <1% | 718 | $1K | |
| 84156 | <1% | 912 | $981.48 | |
| 86880 | <1% | 335 | $962.80 | |
| 84550 | <1% | 582 | $924.04 | |
| 85652 | <1% | 547 | $699.54 | |
| 82010 | <1% | 242 | $589.14 | |
| 86762 | <1% | 127 | $541.39 | |
| 84112 | <1% | 13 | $501.80 | |
| 85384 | <1% | 131 | $393.57 | |
| 87899 | <1% | 41 | $311.58 | |
| 85018 | <1% | 268 | $255.76 | |
| 80177 | <1% | 49 | $235.67 | |
| 80179 | <1% | 13 | $169.65 | |
| 80143 | <1% | 12 | $156.60 | |
| 85014 | <1% | 167 | $148.18 | |
| 83930 | <1% | 36 | $79.22 | |
| 84481 | <1% | 13 | $66.04 | |
| 80164 | <1% | 13 | $57.59 | |
| 85046 | <1% | 12 | $30.14 | |
| 83935 | <1% | 13 | $25.63 | |
| 87077 | 0% | 374 | $0.00 | |
| 86923 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.